Advances in gene and cellular therapeutic approaches for Huntington’s disease
Protein & Cell · 28.05.2025 · 16 (5) · 307-337
DOI: 10.1093/procel/pwae042 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Protein & Cell, online erschienen am 09.08.2024. Verfasst von Xuejiao Piao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Stem Cell Research Center, Peking University Third Hospital, Beijing 100191, China. Hauptthemen laut MEDLINE: Huntington Disease, Genetic Therapy, Cell- and Tissue-Based Therapy. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 221 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, CAMS Innovation Fund for Medical Sciences.
Abstract (Originalsprache)
Huntington’s disease (HD) is an inherited neurodegenerative disorder caused by the abnormal expansion of CAG trinucleotide repeats in the Huntingtin gene (HTT) located on chromosome 4. It is transmitted in an autosomal dominant manner and is characterized by motor dysfunction, cognitive decline, and emotional disturbances. To date, there are no curative treatments for HD have been developed; current therapeutic approaches focus on symptom relief and comprehensive care through coordinated pharmacological and nonpharmacological methods to manage the diverse phenotypes of the disease. International clinical guidelines for the treatment of HD are continually being revised in an effort to enhance care within a multidisciplinary framework. Additionally, innovative gene and cell therapy strategies are being actively researched and developed to address the complexities of the disorder and improve treatment outcomes. This review endeavours to elucidate the current and emerging gene and cell therapy strategies for HD, offering a detailed insight into the complexities of the disorder and looking forward to future treatment paradigms. Considering the complexity of the underlying mechanisms driving HD, a synergistic treatment strategy that integrates various factors—such as distinct cell types, epigenetic patterns, genetic components, and methods to improve the cerebral microenvironment—may significantly enhance therapeutic outcomes. In the future, we eagerly anticipate ongoing innovations in interdisciplinary research that will bring profound advancements and refinements in the treatment of HD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Stem Cell Research Center, Peking University Third Hospital, Beijing 100191, China.
- Beijing Key Laboratory of Reproductive Endocrinology and Assisted Reproductive Technology and Key Laboratory of Assisted Reproduction, Ministry of Education, Center of Reproductive Medicine, Department of Obstetrics and…
ORCID-Profile: Xuejiao Piao, Yang Yu
Förderung
- National Key R&D Program of China
- National Natural Science Foundation of China
- CAMS Innovation Fund for Medical Sciences
Zitieren
APA
Piao, X., Li, D., Liu, H., Guo, Q., & Yu, Y. (2025). Advances in gene and cellular therapeutic approaches for Huntington’s disease. Protein & Cell, 16(5), 307-337. https://doi.org/10.1093/procel/pwae042
Vancouver
Piao X, Li D, Liu H, Guo Q, Yu Y. Advances in gene and cellular therapeutic approaches for Huntington’s disease. Protein & Cell. 2025;16(5):307-337. doi:10.1093/procel/pwae042
BibTeX
@article{Piao2025,
author = {Piao, Xuejiao and Li, Dan and Liu, Hui and Guo, Qing and Yu, Yang},
title = {Advances in gene and cellular therapeutic approaches for Huntington’s disease},
journal = {Protein & Cell},
year = {2025},
volume = {16},
number = {5},
pages = {307--337},
doi = {10.1093/procel/pwae042}
}
EUVIMED